Asset
PEXIGANAN ACETATE
Abeona Therapeutics Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00563433 | phase3 | completed | 1994-08-01 | 1996-07-01 | Abeona Therapeutics, Inc | MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers |
| NCT00563394 | phase3 | completed | 1994-08-01 | 1996-07-01 | Abeona Therapeutics, Inc | MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers |
FDA applications (0)
This company has no applications containing this asset.